GW Pharma (GWPH) Posts Near-Breakeven Q4 Profit

GW Pharma (NASDAQ: GWPH) reported Q4 EPS of $0.00, $0.69 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $12.03 million versus the consensus estimate of $14.6 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c